Stockholders' Equity (Details Narrative) - USD ($)
|
|
|
|
|
|
|
|
|
1 Months Ended |
2 Months Ended |
3 Months Ended |
12 Months Ended |
|
|
|
|
Mar. 17, 2021 |
Feb. 11, 2021 |
Jan. 25, 2021 |
Nov. 22, 2020 |
Sep. 25, 2020 |
Jul. 21, 2020 |
Jul. 06, 2020 |
Feb. 05, 2020 |
Feb. 28, 2021 |
Dec. 31, 2020 |
Jul. 31, 2020 |
Apr. 30, 2020 |
Jun. 17, 2020 |
Mar. 31, 2021 |
Dec. 31, 2020 |
Mar. 31, 2020 |
Dec. 31, 2020 |
Jul. 22, 2020 |
Jul. 17, 2020 |
Jul. 08, 2020 |
Jun. 19, 2020 |
Common stock par value |
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
$ 0.0001
|
$ 0.0001
|
|
$ 0.0001
|
|
|
|
|
Cash proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 58,269,829
|
|
|
|
|
|
|
|
Shares issued for exercised stock options, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 183,425
|
|
|
|
|
|
|
|
Shares issued for exercised stock options |
|
|
|
|
|
|
|
|
|
|
|
|
|
74,987
|
|
|
|
|
|
|
|
Share based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,699,423
|
|
$ 156,458
|
|
|
|
|
|
Preferred stock, designated |
|
|
|
|
|
|
|
|
|
20,000,000
|
|
|
|
20,000,000
|
20,000,000
|
|
20,000,000
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
$ 8.03
|
|
|
|
$ 7.62
|
$ 8.03
|
|
$ 8.03
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
3,501,014
|
|
|
|
7,361,083
|
3,501,014
|
|
3,501,014
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00%
|
|
74.40%
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00%
|
|
0.29%
|
|
|
|
|
|
Expected life |
|
|
|
|
|
|
|
|
|
|
|
|
|
0 years
|
|
5 years
|
|
|
|
|
|
Series H-6 Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
225,590
|
|
|
|
|
|
|
|
|
|
|
Shares issued during conversion, shares |
|
|
|
|
|
|
|
|
|
|
7,833
|
|
|
|
|
|
|
|
|
|
|
Shares issued for exercised stock options, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series H-3 Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued for exercised stock options, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock stated value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 138
|
|
|
|
|
|
|
|
Aggregate issued and outstanding shares percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
9.99%
|
|
|
|
|
|
|
|
Series H Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued for exercised stock options, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock stated value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 154
|
|
|
|
|
|
|
|
Preferred stock, conversion price |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 184.80
|
|
|
|
|
|
|
|
Aggregate issued and outstanding shares percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
9.99%
|
|
|
|
|
|
|
|
Exercise of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series H-6 Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock stated value |
|
|
|
|
|
|
|
$ 72.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, conversion price |
|
|
|
|
|
|
|
$ 3.60
|
|
|
|
|
|
$ 3.60
|
|
|
|
|
|
|
|
Aggregate issued and outstanding shares percentage |
|
|
|
|
|
|
|
9.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, designated |
|
|
|
|
|
|
|
50,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, conversion price description |
|
|
|
|
|
|
|
Each share of Series H-6 Preferred Stock is convertible at any time at the option of the holder thereof, into a number of shares of common stock of the Company determined by dividing the H-6 Stated Value by the initial conversion price of $3.60 per share, which was then further reduced to $2.50 under the anti-dilution adjustment provision, subject to a 9.99% blocker provision.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Advisors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,037,496
|
|
|
|
|
Merger Sub [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,337,663
|
|
|
|
|
Value of common stock issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,060,740
|
|
|
|
|
Restricted Common Stock [Member] | Long-Term Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,087,618
|
|
|
|
|
Number of shares vested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,115
|
|
|
|
|
Weighted average price restricted stock |
|
|
|
|
|
|
|
|
|
$ 5.27
|
|
|
|
|
$ 5.27
|
|
$ 5.27
|
|
|
|
|
Share based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,246,539
|
|
|
|
|
|
|
|
AYRO Seed Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
|
$ 22,056
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
461,647
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7.33
|
|
|
|
|
|
|
|
Warrants term |
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
461,647
|
|
|
|
|
|
|
|
Exercise of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 100,000
|
|
|
|
|
|
|
|
Exercise of warrants, Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
13,642
|
|
|
|
|
|
|
|
Series I Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
14,636
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 69.00
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
14,636
|
|
|
|
|
|
|
|
Warrant weighted average exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 138
|
|
|
|
|
|
|
|
Warrants description |
|
|
|
|
|
|
|
|
|
|
|
|
|
If at any time (i) the volume weighted average price ("VWAP") of the Common Stock exceeds $138.00 for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series I Warrants still unexercised for a cash exercise.
|
|
|
|
|
|
|
|
Series H-3 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
2,800
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 165.60
|
|
|
|
|
|
|
|
Warrants term |
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
2,800
|
|
|
|
|
|
|
|
Series H-4 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
37,453
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 15.60
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
37,453
|
|
|
|
|
|
|
|
Anti-dilution price protection price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 15.60
|
|
|
|
|
|
|
|
Series J Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
52,023
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 30.00
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
52,023
|
|
|
|
|
|
|
|
Warrant weighted average exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 45
|
|
|
|
|
|
|
|
Warrants description |
|
|
|
|
|
|
|
|
|
|
|
|
|
If at any time (i) the VWAP of the Common Stock exceeds $9.00 for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series J Warrants still unexercised for a cash exercise.
|
|
|
|
|
|
|
|
Series H-5 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.77
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
296,389
|
|
|
|
|
|
|
|
Sale of stock price |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.77
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.50
|
|
|
|
|
|
|
|
Warrants term |
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
348,476
|
|
|
|
|
|
|
|
Exercise of warrants, Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
173,091
|
|
|
|
|
|
|
|
Warrants description |
|
|
|
|
|
|
|
|
|
|
|
|
|
The H-5 Warrants are entitled to certain anti-dilution adjustments if the Company issues shares of its common stock at a lower price per share than the applicable exercise price (subject to a floor of $0.792 per share). An anti-dilution adjustment was triggered resulting in an adjusted exercise price per share from $3.96 to $2.50, resulting in an issuance of an additional 173,091 warrants that are exercisable at $2.50 per share.
|
|
|
|
|
|
|
|
Deemed dividend |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 432,727
|
|
|
|
|
|
|
|
Fair value of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
967,143
|
|
|
|
|
|
|
|
Fair value of modification of orinigal award |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 534,416
|
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
89.96%
|
|
|
|
|
|
|
|
Dividend yield |
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00%
|
|
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
0.24%
|
|
|
|
|
|
|
|
Expected life |
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
Series I, H-1, H-3, H-4, J and H-5 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant expiration description |
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expire through the years 2020-2024
|
|
|
|
|
|
|
|
June Finder Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27,273
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.75
|
Warrants term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
June Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
126,000
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.875
|
Warrants term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
July 8 Finder Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
71,770
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.225
|
|
Warrants term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
July 8 Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
147,368
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.4625
|
|
Warrants term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
July 22 Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
129,500
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.750
|
|
|
|
Warrants term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
July 22 Finder Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
September Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
31,348
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 66,845
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
$ 3.19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
31,348
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant expiration description |
|
|
|
|
The September Warrant is immediately exercisable and expires on September 25, 2025.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Decrease in exercise price |
|
|
|
|
$ 2.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November Finder Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
56,256
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
$ 6.6660
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
56,256
|
|
|
|
|
|
|
|
November Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
57,756
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
$ 6.9690
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
57,756
|
|
|
|
|
|
|
|
Warrants description |
|
|
|
The November Finder Warrants and November Placement Agent Warrants terminate after a period of 5 years on November 22, 2025.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
February Finder Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
15,574
|
|
|
|
|
|
|
|
|
|
|
|
51,459
|
|
|
|
|
|
|
|
Warrant exercise price |
|
$ 10.925
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
February Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
255,584
|
|
|
|
|
|
|
|
|
|
|
|
255,584
|
|
|
|
|
|
|
|
Warrant exercise price |
|
$ 10.925
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants term |
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,074,645
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
|
|
|
|
|
|
5,092,806
|
|
|
|
|
5,092,806
|
|
5,092,806
|
|
|
|
|
Cash proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,926,818
|
|
|
|
|
Shares issued for exercised stock options, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7
|
|
|
|
|
|
|
|
Shares issued for exercised stock options |
|
|
|
|
|
|
|
|
|
|
|
|
|
74,987
|
|
|
|
|
|
|
|
Common Stock [Member] | Series H-3 Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
795
|
|
|
|
|
Shares issued during conversion, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
955
|
|
|
|
|
Preferred stock, conversion price |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 165.60
|
|
|
|
|
|
|
|
Common Stock [Member] | February Finder Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
35,885
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price |
|
$ 10.45
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AYRO Seed Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,007,193
|
|
|
|
|
Shares issued during conversion, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,360,985
|
|
|
|
|
Securities Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
4,400,001
|
3,333,334
|
1,650,164
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from sale of common stock |
|
$ 41,800,008
|
$ 20,000,004
|
$ 10,000,000
|
|
$ 1,512,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering expenses |
|
$ 3,394,054
|
$ 1,648,608
|
847,619
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
$ 6.93
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant purchase price |
|
|
$ 233,334
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities Purchase Agreement [Member] | Series A Warrants and Series B [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value of common stock issued |
|
|
|
$ 9,999,997
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities Purchase Agreement [Member] | Series A Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
1,237,624
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
$ 8.09
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants description |
|
|
|
Terminate six months from the date of issuance on May 24, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities Purchase Agreement [Member] | Series B Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase common stock |
|
|
|
825,084
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
$ 8.90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants description |
|
|
|
Terminate five years from the date issuance on November 24, 2025.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities Purchase Agreement [Member] | Additional Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
420,000
|
|
|
|
|
Common stock par value |
|
$ 0.0001
|
$ 0.0001
|
$ 0.0001
|
|
$ 0.0001
|
|
|
|
$ 0.0001
|
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
|
|
|
Offering price |
|
$ 9.50
|
$ 6.00
|
$ 6.06
|
|
$ 5.00
|
|
|
|
5.00
|
|
|
|
|
5.00
|
|
$ 5.00
|
|
|
|
|
Proceeds from sale of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,100,000
|
|
|
|
|
Offering expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
168,000
|
|
|
|
|
Purchase of additional shares description |
(i) sell up to 5% of such stockholder's holdings in the Company's common stock on any trading day (with such 5% limitation to be measured as of the date of each sale) and (ii) allow for unlimited sales of the Company's common stock for any sales made at $10.00 per share or greater.
|
Each purchaser was also granted an option to purchase, on or before February 16, 2022, additional shares of common stock equal to the full amount of 75% of the common stock it purchased at the initial closing, or an aggregate of 3,300,001 shares, at an exercise price of $11.50 per share.
|
|
|
|
Each purchaser also had the right to purchase, on or before October 19, 2020, additional shares of common stock (the "Additional Shares") equal to the full amount of 75% of the common stock it purchased at the initial closing, or an aggregate of 1,387,500 shares, at price of $5.00 per share.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued for exercised stock options, shares |
|
|
|
|
|
|
|
|
$ 74,987
|
|
|
|
|
|
|
|
$ 6,817
|
|
|
|
|
Shares issued for exercised stock options |
|
|
|
|
|
|
|
|
183,425
|
|
|
|
|
|
|
|
16,669
|
|
|
|
|
Securities Purchase Agreement [Member] | Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from sale of common stock |
|
|
|
|
|
|
|
|
$ 100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued for exercised stock options |
|
|
|
|
|
|
|
|
13,642
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities Purchase Agreement [Member] | Investors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of stock sold |
|
|
|
|
|
1,850,000
|
3,157,895
|
|
|
|
|
|
2,200,000
|
|
|
|
|
|
|
|
|
Common stock par value |
|
|
|
|
|
$ 0.0001
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
Offering price |
|
|
|
|
|
$ 5.00
|
$ 4.75
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.50
|
|
|
Proceeds from sale of common stock |
|
|
|
|
|
$ 9,250,000
|
$ 15,000,000
|
|
|
|
|
|
$ 5,500,000
|
|
|
|
|
|
|
|
|
Offering expenses |
|
|
|
|
|
$ 740,000
|
$ 1,249,200
|
|
|
|
|
|
$ 435,000
|
|
|
|
|
|
|
|
|
Stock Purchase Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,573,218
|
|
|
|
|
Common stock par value |
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
|
|
|
Offering expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 609,010
|
|
|
|
|
Cash proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,000,000
|
|
|
|
|
Core IR [Member] | Restricted Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
Core IR [Member] | Restricted Common Stock [Member] | General and Administrative Expense [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 42,300
|
|
|
|
|
Bridge Notes [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
553,330
|
|
|
|
|
|
|
|
|
|
Value of common stock issued |
|
|
|
|
|
|
|
|
|
|
|
$ 600,000
|
|
|
|
|
|
|
|
|
|
Convertible Bridge Notes [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued during conversion, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,030,585
|
|
|
|
|
Shares issued during conversion |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,000,000
|
|
|
|
|